Study investigated therapeutic potential of plant extract for cancer, diabetes, and wound healing. Extract showed promising anticancer, antidiabetic, and wound healing activities. Contains key bioactive compounds. Could lead to new herbal treatments.
Researchers studied compounds from Acronychia pedunculata for potential inhibition of HER2 in colorectal cancer. 12 compounds showed promising properties for drug-likeness and oral bioavailability, with two compounds showing strong binding affinities to HER2. Further experimental validation is needed.
Extracted compounds from Parkinson Fosberg bark showed promising cytotoxic effects on oral cancer cells by modulating protein expression and signaling pathways. Potential avenue for effective oral cancer management.
Study explores potential anti-cancer effects of (Bunge) Kitag. ex H.Hara in pancreatic cancer. CPAE inhibits proliferation, induces apoptosis, and suppresses metastasis. Promising herbal medicine for pancreatic cancer treatment.
Researchers studied chemoresistance in colorectal cancer cells treated with 5-FU, finding various resistance mechanisms. Curcumin and piperine enhance 5-FU sensitivity, showing promise for improving chemotherapy effectiveness.
Researchers are looking into the use of the phytochemical nimbolide (found in Azadirachta indica) as a potential treatment for pancreatic cancer. Nimbolide has shown promising anticancer properties in preclinical studies, but further research is needed to determine its safety and effectiveness in human trials.
Andrographolide, a natural compound from Andrographis paniculata, shows promising anti-cancer properties, inhibiting multiple signaling pathways and causing anti-proliferative and apoptotic effects. It has no side effects and potential as a new cancer treatment, but more research is needed for full understanding and clinical application.
Plant-extracted ZnO NPs show potential as eco-friendly cancer treatment. Biosynthesized by Rhus coriaria fruit extract, they exhibit anti-tumor effects and induce apoptosis in breast cancer cells. Exciting implications for cancer nanotechnology.